S&P 500   3,837.75 (+1.84%)
DOW   31,465.24 (+1.75%)
QQQ   308.88 (+1.57%)
AAPL   121.36 (+1.02%)
MSFT   232.79 (+2.67%)
FB   264.09 (+2.50%)
GOOGL   2,092.62 (+2.89%)
TSLA   599.16 (-3.59%)
AMZN   3,002.16 (+0.83%)
NVDA   499.01 (+0.85%)
BABA   234.90 (+1.91%)
CGC   30.98 (-0.10%)
GE   13.52 (-0.37%)
MU   89.13 (+5.69%)
NIO   37.75 (-3.90%)
AMD   78.73 (+1.26%)
T   29.67 (+2.59%)
F   12.25 (+2.68%)
ACB   9.55 (-2.75%)
DIS   190.00 (+1.05%)
BA   222.48 (-0.99%)
NFLX   514.13 (+0.56%)
BAC   36.93 (+1.18%)
S&P 500   3,837.75 (+1.84%)
DOW   31,465.24 (+1.75%)
QQQ   308.88 (+1.57%)
AAPL   121.36 (+1.02%)
MSFT   232.79 (+2.67%)
FB   264.09 (+2.50%)
GOOGL   2,092.62 (+2.89%)
TSLA   599.16 (-3.59%)
AMZN   3,002.16 (+0.83%)
NVDA   499.01 (+0.85%)
BABA   234.90 (+1.91%)
CGC   30.98 (-0.10%)
GE   13.52 (-0.37%)
MU   89.13 (+5.69%)
NIO   37.75 (-3.90%)
AMD   78.73 (+1.26%)
T   29.67 (+2.59%)
F   12.25 (+2.68%)
ACB   9.55 (-2.75%)
DIS   190.00 (+1.05%)
BA   222.48 (-0.99%)
NFLX   514.13 (+0.56%)
BAC   36.93 (+1.18%)
S&P 500   3,837.75 (+1.84%)
DOW   31,465.24 (+1.75%)
QQQ   308.88 (+1.57%)
AAPL   121.36 (+1.02%)
MSFT   232.79 (+2.67%)
FB   264.09 (+2.50%)
GOOGL   2,092.62 (+2.89%)
TSLA   599.16 (-3.59%)
AMZN   3,002.16 (+0.83%)
NVDA   499.01 (+0.85%)
BABA   234.90 (+1.91%)
CGC   30.98 (-0.10%)
GE   13.52 (-0.37%)
MU   89.13 (+5.69%)
NIO   37.75 (-3.90%)
AMD   78.73 (+1.26%)
T   29.67 (+2.59%)
F   12.25 (+2.68%)
ACB   9.55 (-2.75%)
DIS   190.00 (+1.05%)
BA   222.48 (-0.99%)
NFLX   514.13 (+0.56%)
BAC   36.93 (+1.18%)
S&P 500   3,837.75 (+1.84%)
DOW   31,465.24 (+1.75%)
QQQ   308.88 (+1.57%)
AAPL   121.36 (+1.02%)
MSFT   232.79 (+2.67%)
FB   264.09 (+2.50%)
GOOGL   2,092.62 (+2.89%)
TSLA   599.16 (-3.59%)
AMZN   3,002.16 (+0.83%)
NVDA   499.01 (+0.85%)
BABA   234.90 (+1.91%)
CGC   30.98 (-0.10%)
GE   13.52 (-0.37%)
MU   89.13 (+5.69%)
NIO   37.75 (-3.90%)
AMD   78.73 (+1.26%)
T   29.67 (+2.59%)
F   12.25 (+2.68%)
ACB   9.55 (-2.75%)
DIS   190.00 (+1.05%)
BA   222.48 (-0.99%)
NFLX   514.13 (+0.56%)
BAC   36.93 (+1.18%)
Log in
NASDAQ:ESPR

Esperion Therapeutics SEC Filings & 10K Form

$29.03
+1.57 (+5.72 %)
(As of 03/5/2021 03:14 PM ET)
Add
Compare
Today's Range
$27.22
Now: $29.03
$29.14
50-Day Range
$25.12
MA: $29.53
$36.89
52-Week Range
$23.90
Now: $29.03
$56.10
Volume40,794 shs
Average Volume946,267 shs
Market Capitalization$811.19 million
P/E RatioN/A
Dividend YieldN/A
Beta1.48

SEC Filings

Esperion Therapeutics (NASDAQ:ESPR) SEC Filings

DateFilerForm TypeView
02/23/2021
4:17 PM
Esperion Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/23/2021
4:15 PM
Esperion Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/23/2021
3:15 PM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2021
12:03 PM
Esperion Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
02/09/2021
1:56 PM
Esperion Therapeutics (Subject)
WASATCH ADVISORS INC (Filed by)
Form SC 13G/A
01/29/2021
4:01 PM
Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2021
4:01 PM
Bartram Richard (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2021
4:01 PM
Esperion Therapeutics (Issuer)
Hall Ashley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2021
4:00 PM
Esperion Therapeutics (Issuer)
Koenig Sheldon L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2021
6:00 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2021
1:37 PM
Esperion Therapeutics (Subject)
Meditor Group Ltd (Filed by)
Form SC 13G/A
12/31/2020
3:09 PM
Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2020
6:36 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/15/2020
6:48 AM
Esperion Therapeutics (Issuer)
Koenig Sheldon L. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/15/2020
6:32 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2020
1:36 PM
Esperion Therapeutics (Subject)
WASATCH ADVISORS INC (Filed by)
Form SC 13G
11/16/2020
4:15 PM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2020
6:01 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2020
3:37 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2020
4:21 PM
Esperion Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/02/2020
3:28 PM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2020
4:18 PM
Esperion Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/10/2020
4:16 PM
Esperion Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/22/2020
7:00 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2020
3:44 PM
Esperion Therapeutics (Subject)
MARSHALL WACE, LLP (Filed by)
Form SC 13G
05/29/2020
3:42 PM
Berkowitz Jeffrey (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2020
3:41 PM
Esperion Therapeutics (Issuer)
Fuhrman Alan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2020
3:32 PM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2020
4:26 PM
Esperion Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/20/2020
7:01 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2020
9:34 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/06/2020
6:15 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2020
7:07 AM
Esperion Therapeutics (Issuer)
Fuhrman Alan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/18/2020
7:00 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2020
6:34 AM
Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2020
5:16 AM
Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2020
6:30 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2020
4:12 PM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2020
11:51 AM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
7:23 AM
Esperion Therapeutics (Subject)
Meditor Group Ltd (Filed by)
Form SC 13G/A
01/03/2020
3:27 PM
Esperion Therapeutics (Issuer)
Glickman Mark A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
3:27 PM
Bartram Richard (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
3:27 PM
Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2019
1:54 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2019
3:30 PM
Esperion Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2019
7:30 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2019
3:22 PM
Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2019
3:09 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2019
3:30 PM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2019
3:32 PM
Esperion Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2019
7:00 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2019
11:42 AM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2019
3:57 PM
Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2019
4:18 PM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2019
5:09 PM
Esperion Therapeutics (Issuer)
VITULLO NICOLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:52 PM
Esperion Therapeutics (Issuer)
Woody Tracy M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:52 PM
Braunstein Scott (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:52 PM
Berkowitz Jeffrey (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:51 PM
Esperion Therapeutics (Issuer)
JANNEY DANIEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:51 PM
Esperion Therapeutics (Issuer)
GOTTO ANTONIO M JR MD D PHIL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:50 PM
Esperion Therapeutics (Issuer)
MCGOVERN MARK E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:50 PM
Esperion Therapeutics (Issuer)
Shepard Jay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:49 PM
Esperion Therapeutics (Issuer)
Woody Tracy M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/30/2019
3:32 PM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2019
3:30 PM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2019
3:32 PM
Esperion Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2019
7:01 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2019
3:30 PM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2019
3:32 PM
Esperion Therapeutics (Filer)
Form DEF 14A
04/05/2019
4:23 PM
Bartram Richard (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2019
3:41 PM
Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2019
4:01 PM
Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2019
8:02 AM
Esperion Therapeutics (Issuer)
VITULLO NICOLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2019
6:50 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2019
3:57 PM
Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2019
3:57 PM
Esperion Therapeutics (Issuer)
NEWTON ROGER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
3:50 PM
Esperion Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/28/2019
3:45 PM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
4:22 PM
Esperion Therapeutics (Subject)
Partner Fund Management, L.P. (Filed by)
Form SC 13G/A
02/14/2019
3:30 PM
Esperion Therapeutics (Subject)
Pentwater Capital Management LP (Filed by)
Form SC 13G/A
02/14/2019
10:16 AM
Esperion Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
02/11/2019
1:17 PM
Esperion Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
01/07/2019
4:10 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2019
6:45 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2019
9:57 AM
Esperion Therapeutics (Subject)
Meditor Group Ltd (Filed by)
Form SC 13G/A
12/26/2018
10:44 AM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
4:07 PM
Esperion Therapeutics (Issuer)
Glickman Mark A (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/21/2018
4:03 PM
Esperion Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/21/2018
4:03 PM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2018
12:14 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2018
4:18 PM
Bartram Richard (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2018
4:17 PM
Esperion Therapeutics (Issuer)
Lalwani Narendra D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2018
4:15 PM
Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2018
6:56 PM
Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Esperion Therapeutics (Issuer)
LEWIS JOSEPH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2018
4:00 PM
Esperion Therapeutics (Issuer)
NEWTON ROGER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2018
3:20 PM
Esperion Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/30/2018
3:35 PM
Boxer Capital, LLC (Filed by)
Esperion Therapeutics (Subject)
Form SC 13G/A
10/30/2018
3:33 PM
Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Braslyn Ltd. (Reporting)
Esperion Therapeutics (Issuer)
LEWIS JOSEPH (Reporting)
Tuesday Thirteen Inc. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/29/2018
6:45 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2018
4:05 PM
Esperion Therapeutics (Issuer)
NEWTON ROGER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 3/5/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.